​

Funding Round

Series D - Biolinq

Series D - Biolinq

Investment Firm

Overview

Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.

Announced Date

Apr 04, 2024

Closed on Date

Apr 04, 2024

Funding Type

Series D

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Alpha Wave Ventures

Alpha Wave Ventures

Alpha Wave Ventures is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

9

Investor Name
Participant InvestorAlpha Wave Ventures
Participant InvestorAXA Investment Managers
Participant InvestorAphelion Capital
Participant InvestorRiverVest
Participant InvestorPegasus Tech Ventures

Round Details and Background

Biolinq raised $58000000 on 2024-04-04 in Series D

Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 02, 2021
Series B - Biolinq
18-100.0M
May 07, 2022
Venture Round - Biolinq
-77.9M
Jan 01, 2014
Seed Round - Biolinq
1-undefined
Apr 04, 2024
Series D - Biolinq
10-58.0M

Recent Activity

There is no recent news or activity for this profile.